Loading chat...
NY A00115
Bill
Status
1/8/2025
Primary Sponsor
Sam Berger
Click for details
AI Summary
-
Requires annual health reports to include a list of the ten highest-cost prescription drugs with wholesale acquisition cost increases of 50% or more over five years or 10% or more in the previous year, ranked by size of increase
-
Mandates a separate list of the ten highest-cost drugs where net cost to the state (after rebates and price concessions) has increased by 50% over five years or 10% in the previous year
-
Requires drug manufacturers whose products appear on either list to submit reports explaining factors contributing to price increases, including manufacturing costs, R&D spending, marketing expenses, and patient assistance programs
-
Manufacturer reports must disclose the percentage of price increase attributable to each factor, total revenue, and net profit for the most recent calendar year
-
Amends the preferred drug program review requirements under the public health law to incorporate these prescription drug cost transparency measures
Legislative Description
Requires the commissioner of health to include in annual reports information regarding the cost and increase in cost of the ten prescription drugs on which the state expends the most money and which have had certain costs increased by fifty percent or more over the past five years or by ten percent or more during the previous calendar year.
Last Action
referred to health
1/7/2026